Ultrasound and multi-biomarker disease activity score for assessing and predicting clinical response to tofacitinib treatment in patients with rheumatoid arthritis.

导出 LinkOut

翻译打印收藏纠错

作者： Amir A,Razmjou ^[1] ; Jenny,Brook ^[2] ; David,Elashoff ^[2] ; Gurjit,Kaeley ^[3] ; Soo,Choi ^[4] ; Tanaz,Kermani ^[5] ; Veena K,Ranganath ^[5]

作者单位： Department of Medicine, UCLA-David Geffen School of Medicine, Los Angeles, USA. ^[1] Department of Medicine Statistics Core, UCLA-David Geffen School of Medicine, Los Angeles, USA. ^[2] Department of Rheumatology, University of Florida Health, Jacksonville, USA. ^[3] Department of Rheumatology, University of California, San Diego, USA. ^[4] Department of Rheumatology, UCLA-David Geffen School of Medicine, 1000 Veteran Blvd., RM 32-59, Los Angeles, CA 90095 USA. ^[5]

关键词 Multi-biomarker disease activity score Outcome measures Rheumatoid arthritis Ultrasound

DOI 10.1186/s41927-020-00153-4

PMID 33089069

发布时间 2022-04-17

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

BMC rheumatology

2020年4卷

55页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Ultrasound and multi-biomarker disease activity score for assessing and predicting clinical response to tofacitinib treatment in patients with rheumatoid arthritis.

BMC rheumatology

相似文献

BMC rheumatology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Ultrasound and multi-biomarker disease activity score for assessing and predicting clinical response to tofacitinib treatment in patients with rheumatoid arthritis.

BMC rheumatology

相似文献

BMC rheumatology

相关期刊

检索历史清除